Aortic Bicuspid/Mitral Coronary Artery Bypass Graft 
DAIC
APRIL 30, 2024
SAVR after TAVR Surgical aortic valve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. The analysis found that mitral replacement increases the risk of operative mortality and other adverse outcomes compared to mitral repair. Adding CABG also increased these risks uniformly.
DAIC
FEBRUARY 26, 2024
The academic medical centers received three-star ratings in isolated coronary artery bypass grafting (CABG) and isolated mitral valve replacement and repair (MVRR) surgeries. Jersey Shore University Medical Center also received a three-star rating in isolated aortic valve replacement (AVR) surgery.
DAIC
DECEMBER 20, 2023
It evaluates performance in five surgical categories, including isolated coronary artery bypass grafting (CABG), isolated aortic valve replacement (AVR) surgery, CABG + AVR surgery, isolated mitral valve repair/replacement (MVRR), and CABG + mitral valve replacement/repair surgery (CABG + MVRR).
DAIC
DECEMBER 18, 2023
It uses a three-star scale (3=better than expected, 2=as expected, 1=worse than expected) to rate institutions across five common cardiovascular procedures: coronary artery bypass grafting (CABG); aortic valve replacement (AVR); AVR and CABG; mitral valve replacement/repair (MVRR); and MVRR and CABG.
Society of Thoracic Surgeons - Congenital
APRIL 22, 2024
STS leveraged contemporary national data from the STS Adult Cardiac Surgery Database between July 2017 and December 2023 to analyze outcomes of 32,938 patients that underwent multi-valve surgery involving replacement of the aortic valve, plus replacement or repair of the mitral valve, with and without concomitant coronary artery bypass grafting.
Frontiers in Cardiovascular Medicine
MAY 19, 2024
IntroductionTranscatheter mitral valve replacement (TMVR) is a valuable treatment option in patients with severe mitral regurgitation. Prior transapical transcatheter aortic valve replacement (TA-TAVR) may complicate the procedure and is therefore considered a relative contraindication.
Open Heart
JANUARY 21, 2022
per year) and concomitant coronary artery bypass grafting versus isolated valve surgery (HR 0.58, 95% CI 0.35 to 4.01) and aortic valve disease versus mitral valve disease (HR 2.16, 95% CI 1.20 Increasing age (HR 0.97, 95% CI 0.95 Being a man (HR 2.30, 95% CI 1.32
Expert insights. Personalized for you.
111 
Let's personalize your content